Response Biomedical Response Biomedical Inks Distribution Deal with Fisher HealthCare NEW YORK (GenomeWeb News) – Response Biomedical today said that it has signed a new, nonexclusive deal for Fisher HealthCare to distribute its portfolio of infectious disease tests in the US. LABSCO Distributing Response Biomedical's Cardiovascular Test Products in US NEW YORK (GenomeWeb News) – Response Biomedical announced on Thursday a US distribution deal covering its cardiovascular portfolio of Ramp products. Cardiovascular Business Drives Response Biomedical Q3 Revenues up 69 Percent NEW YORK (GenomeWeb News) – Response Biomedical said today that revenues in the third quarter increased 69 percent year over year. Response Biomedical Regains Rights to Flu, RSV Tests after Termination of 3M Deal NEW YORK (GenomeWeb News) – Response Biomedical said today that as a result of the termination of a collaboration with 3M and 3M Innovative Properties, it has regained the worldwide rights to Flu A+B and respiratory syncytial virus products. Response Biomedical Completes Share Consolidation NEW YORK (GenomeWeb News) – Response Biomedical has completed a 20-for-one share consolidation, the Vancouver, British Columbia-based firm said yesterday after the close of the market. Aug 8, 2012 Cardiovascular Sales Help Raise Response Biomedical's Q2 Revenues 10 Percent Aug 3, 2012 People in the News: Jonathan Wang and Pablo Moscato Premium Jul 27, 2012 People in the News: Response Biomedical and BioTheranostics Premium Jul 17, 2012 Response Biomedical Receives $280K to Support its Diagnostic Platform May 8, 2012 Response Biomedical's Q1 Sales Bounce 50 Percent Mar 29, 2012 Response Biomedical 2011 Revenues Improve 32 Percent Nov 30, 2011 Response Biomedical Files Prospectus to Raise $7.9M Nov 23, 2011 Response Biomedical Inks C$2M Debt Financing Pact Nov 17, 2011 Response Biomedical Files for $7.8M Raise Nov 10, 2011 Response Biomedical Files Restated Financials Sep 30, 2011 Response Biomedical Restates Earnings Results After Ongoing Internal Review Sep 2, 2011 Roche Diagnostics Terminates Deal to Market Response Bio's Cardiovascular Panel Aug 15, 2011 Response Biomedical CEO Resigns Aug 10, 2011 Response Biomedical's Q2 Revenues Rise 17 Percent; Heart Assay for New System Fails to Clear FDA May 11, 2011 Response Biomedical's Q1 Revenues Jump 67 Percent May 4, 2011 Fisher Scientific to Distribute Response Bio's Ramp Cardiac Product in Canada Apr 29, 2011 Response Biomedical Receives Chinese Clearance for Ramp 200 Mar 11, 2011 Response Biomedical Posts 23 Percent Decline in 2010 Revenues Jan 4, 2011 Response Biomedical Reaches Italian Distribution Deal for Cardiac Test Products Nov 3, 2010 Pairings: Nov 3, 2010 Premium Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.